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Modified Live Virus 
Hog Cholera Vaccine-M.L.V. 
H. E. Pinkerton, D.V.M.* 
Editors Note: This is the second article of a 
series which will deal with new products avail-
able to veterinarians. The first article of the 
rcew series appeared in Vol. XIV, No.2, 1952. 
D URING THE PAST several months 
great interest has been shown, es-
pecially by veterinarians and swine grow-
ers, in the new modified live-virus vac-
cines for use in vaccination of swine a-
gainst hog cholera. These vaccines have 
been given wide publicity through articles 
appearing in newspapers, farm journals 
and veterinary publications. Some of these 
articles have been misleading and tend 
to create a false impression by seeming 
to imply that all modified live-virus vac-
cines are alike or that there is but one 
such vaccine. 
All modified live-virus vaccines now 
approved for sale are similar in that mod-
ification in virulence of the virus used in 
their preparation is accomplished by pas-
sage through other than the natural host. 
They are similar also in that all are vacu-
um-dried and vacuum-sealed. However, 
they differ widely in techniques of modifi-
cation and production. 
The modified live-virus hog-cholera 
vaccine now produced by the Fort Dodge 
Laboratories, Inc. under the trade name 
of M.L.V. was the first modified live-
virus vaccine to be licensed for general 
use and is the only one of porcine origin 
to date. It was developed from a strain 
of hog cholera virus which had been suc-
cessfully modified in virulence by Dr. 
J ames A. Baker in work at Rockefeller 
Institute, through use of the technique 
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of serial passage in rabbits. This strain 
of virus previously had been successfully 
grown in eggs, but without attenuation 
of virulence, by TenBroeck of Rockefeller 
Institute through addition of minced 
swine testicle to the inoculum. The virus 
also has been grown in tissue culture, with 
swine tissue as the source of living cells, 
by Hecke, TenBroeck and Boynton. 
Following Baker's successful attenua-
tion of this virus, designated by him as 
"Strain A," this project was taken up by 
Fort Dodge Laboratories for the purpose 
of adapting Baker's method of attenua-
tion to production of a vaccine for general 
use in hog cholera control. 
It was known that passage in rabbits did 
not materially alter the antigenic proper-
ties of the virus, but did modify the vir-
ulence to the extent that the virus no 
longer was capable of producing hog 
cholera when injected into susceptible 
pigs. Therefore, it seemed logical to as-
sume that a single-injection vaccine could 
be developed by this method which would 
be safe for use in routine vaccination of 
swine against hog cholera. It was soon 
discovered, however, that, while such a 
single-injection vaccine could be used 
safely and satisfactorily under ideal con-
ditions and circumstances. its use under 
less favorable conditions was frequently 
attended by undesirable results. Many 
situations encountered during the vaccin-
ating season are far from ideal and it is 
practically impossible to determine ac-
curately to what extent vaccination re-
sults might be adversely affected under 
such conditions. 
It has been shown that anti-hog cholera 
serum, in sufficient amounts, is always 
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safe and usually is highly beneficial when 
used in such situations. 
In order to be able to cope with condi-
tions such as occur when there is doubt 
as to the state of health and nutrition of 
the swine to be vaccinated, or when there 
is possibility of exposure to hog cholera 
before immunity can be established, it 
seemed desirable to develop a vaccina-
tion procedure in which modified live 
virus would be used with anti-hog cholera 
serum. 
During development of this idea it was 
demonstrated that a modified live-virus 
vaccine, produced from swine tissues 
rather than rabbit tissues, could be used 
simultaneously with varying amounts 
of anti-hog cholera serum without antag-
onistic action by the serum. Therefore, 
M.L.V. was developed as a rabbit-modi-
fied, swine-propagated vaccine for simul-
taneous use in vaccination of healthy 
swine in a 2 cc. dose together with such 
amounts of anti-hog cholera serum as the 
existing situation seemed to require. Fort 
Dodge Laboratories has been granted a 
patent on this product. 
By this simultaneous method of vaccin-
ation, immediate protection against hog 
cholera is provided during the time be-
tween vaccination and the establishment 
of active immunity. 
This immediate protection was demon-
strated by the administration of virulent 
hog cholera virus to various groups of 
pigs at hourly intervals on the first day 
and, subsequently, at daily intervals 
through the 14th day after vaccination 
with M.L.V. and 15 cc. doses of serum. All 
groups were resistant to the virus chal-
lenge. It was further demonstrated that 
a full prophylactic dose of serum, such as 
would be indicated with virulent virus, 
could be used with M.L.V. when it be-
came necessary or desirable to vaccinate 
susceptible swine which had undergone 
exposure to other infections in sales-
barns or public stockyards. 
Practicality of the simultaneous use of 
M.L.V. and anti-hog cholera serum was 
determined through supervision of rou-
tine vaccination of several thousand swine 
by practicing veterinarians in North Cen-
tral Iowa. The immunity response was 
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demonstrated by virus challenge of at 
least three individuals from each herd 
at market weight. About one-third of the 
pigs in this experiment were around 5 to 
7 weeks of age at the time of vaccination 
and were still nursing. No appreciable 
difference could be demonstrated between 
their resistance to challenge and that of 
pigs that were weaned before vaccination. 
General field use of M.L.V. on young 
unweaned pigs has further proved the 
practicality of such procedure. 
This practice is in accord with official 
recommendations for vaccination of young 
pigs before they are weaned as a possible 
means of avoiding some of the undesirable 
conditions which sometimes develop fol-
lowing vaccination of older swine. 
M.L.V. is a vacuum-dried and vacuum-
sealed product, and must be restored to 
liquid form by adding the diluent which 
accompanies each package. Care should 
be taken to prevent contamination during 
this process. The restored vaccine should 
be kept refrigerated and used within 24 
hours following restoration. 
M.L.V. is recommended in a 2 cc. dose 
with a 15 cc. dose of anti-hog cholera 
serum in vaccination of healthy swine. 
Larger doses of serum may be used in any 
situation where, in the judgement of the 
veterinarian, more serum seems to be 
indicated. The function of the serum is 
to confer immediate protection against 
hog cholera and increased resistance to 
many seconda~y diseases. Therefore, lar-
ger doses of serum always should be used 
with M.L.V. in vaccination of swine with 
unknown history, those which may have 
been exposed in hog cholera or other di-
sease, and those which will be subjected 
to such exposure soon after vaccination. 
Over a million doses of M.L.V. have 
now been used by practicing veterinar-
ians throughout the country and reports 
from them indicate universal satisfaction 
where the product was used as ·directed. 
M.L.V. and serum may be used in any 
situation where virulent virus and serum 
can be used and with little danger of 
adding to any existing disease or distur-
bance. However, best results can be ex-
pected only when the swine are healthy 
and in proper condition for vaccination. 
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